A 23-year-old man with a 3-year history of essential hypertension presented to the emergency department with blurred vision in his right eye for 2 weeks. His visual acuity was 6/30 in his right eye, and 6/12 in his left eye. Dilated fundus examination showed bilateral malignant hypertensive retinopathy and serous macular detachments (Figure 1). His blood pressure was 222/157 mm Hg. The patient had stopped his antihypertensive medications 1 month previously. There was no secondary cause for his hypertension, or other hypertensive target organ damage. Six weeks after resuming his regular medications, the patient’s vision improved to 6/9 in both eyes with regression of the fundus changes.
Signs of hypertensive retinopathy can be detected in 2%–14% of the nondiabetic population aged 40 years and older and it has been identified as a risk marker for stroke and cardiovascular mortality.1 Retinal microvascular changes in hypertensive retinopathy, which can be visualized on fundoscopy, are classified as mild, moderate or malignant, using the Mitchell–Wong system.1 Generalized retinal arteriolar narrowing and arteriovenous nipping suggest chronic hypertensive damage. More transient effects, reflecting current blood pressure, include focal arteriolar narrowing, retinal hemorrhages, microaneurysms and cotton-wool spots.2 Malignant hypertension may cause disc swelling due to optic nerve ischemia, and serous macular detachment secondary to fibrinoid necrosis of choroidal arterioles.1 Retinopathy findings regress with control of blood pressure.1,2 Medication nonadherence is a challenge in managing hypertension and has been shown in a recent meta-analysis to occur in about 45% of patients.3
Footnotes
Competing interests: None declared.
This article has been peer reviewed.
The authors have obtained patient consent.